Learn More
PURPOSE The logic behind the application of luteinizing hormone-releasing hormone (LHRH) agonists in combination with tamoxifen in premenopausal women is that LHRH agonists on the one hand suppress(More)
Meta‐analysis of all clinical data was conducted to compare toremifene 40–60 mg/day (TOR) with tamoxifen 20–40 mg/day (TAM) in postmenopausal women with estrogen receptor (ER) positive or ER unknown(More)